Thrombophilia Gene Testing
Approximately 1 in 7 people suffers from thrombophilia. MyThrombogene® is a genetic test designed to investigate inherited factors associated with an increased predisposition to venous thrombosis. Genetic testing may provide additional information for thromboembolic risk assessment in selected individuals, alongside personal and family history and other clinical risk factors. Results should be interpreted within the appropriate clinical context.
When should you be screened for thrombophilia?
Thrombosis usually occurs after the age of 40 and after exposure to various risk factors, but there is the possibility that it is also inherited.
It is due to the incorrect action of the factors of the hemostasis regulation mechanism.
In case there is a genetic predisposition, we have a correspondingly higher chance of clot formation after exposure to specific risk factors.
The test is performed on 1 vial of EDTA blood or a saliva sample.